fingolimod hydrochloride has been researched along with Interstitial Nephritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JF; Liu, BC; Liu, H; Ma, KL; Ni, HF; Pan, MM; Tang, RN; Zhang, JD; Zhang, MH | 1 |
| Ding, LH; Liu, BC; Liu, D; Liu, H; Lv, LL; Ma, KL; Tang, RN; Wen, Y; Wu, M; Xu, M | 1 |
2 other study(ies) available for fingolimod hydrochloride and Interstitial Nephritis
| Article | Year |
|---|---|
FTY720 attenuates tubulointerstitial inflammation and fibrosis in subtotally nephrectomized rats.
Topics: Animals; Cell Movement; Chemokine CCL2; Disease Models, Animal; Fibrosis; Fingolimod Hydrochloride; Immunosuppressive Agents; Interleukin-6; Kidney Tubules; Lymphocytes; Male; Nephrectomy; Nephritis, Interstitial; Propylene Glycols; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Sphingosine; Transforming Growth Factor beta1; Treatment Outcome; Tumor Necrosis Factor-alpha | 2013 |
FTY720 inhibits tubulointerstitial inflammation in albumin overload-induced nephropathy of rats via the Sphk1 pathway.
Topics: Acetylglucosaminidase; Albuminuria; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Down-Regulation; Fingolimod Hydrochloride; Immunosuppressive Agents; Inflammation Mediators; Kidney Tubules; Lymphocytes; Lysophospholipids; Macrophages; Male; Nephritis, Interstitial; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Rats, Wistar; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors; Time Factors | 2014 |